Analysis of prognostic factors for survival in the Russian population of patients with disseminated gastric cancer, who received ramucirumab as secondline therapy in the RAMSELGA trial
Besova, N. S., Titova, T. A., Artamonova, Е. V., Tryakin, A. A., Stroyakovskiy, D. L., Perminova, E. V., Yukalchuk, D. Yu, Ponomarenko, D. M., Belyak, N. P., Orlova, R. V., Teletaeva, G. M., Ratner, E. Yu, Mochalova, A. S., Gordeeva, O. O., Zhabina, A. S., Gamayunov, S. V., Smolin, A. V., Povyshev, A. Yu, Andrievskikh, M. I., Stilidi, I. S.
Published in Medicinskij sovet (30.07.2020)
Published in Medicinskij sovet (30.07.2020)
Get full text
Journal Article
Tolerance of ramucirumab in the second-line therapy of patients with disseminated gastric cancer in the routine clinical practice of Russia
Besova, N. S., Titova, T. A., Artamonova, E. V., Stroyakovskiy, D. L., Perminova, E. V., Yukal’chuk, D. Yu, Ponomarenko, D. M., Belyak, N. P., Orlova, R. V., Teletaeva, G. M., Ratner, E. Yu, Mochalova, A. S., Gordeeva, O. O., Zhabina, A. S., Gamayunov, S. V., Smolin, A. V., Povyshev, A. Yu, Andrievskikh, M. I., Tryakin, A. A., Stilidi, I. S.
Published in Medicinskij sovet (09.12.2019)
Published in Medicinskij sovet (09.12.2019)
Get full text
Journal Article
Eribulin-trastuzumab combination in HER2-positive metastatic breast cancer: updated results from a Russian observational study
Kovalenko, E. I., Artamonova, E. V., Bolotina, L. V., Zhiliaeva, L. A., Ponomarenko, D. M., Karabina, E. V., Mukhametshina, G. Z., Khasanova, A. I., Ratner, E. Yu, Safarova, A. R., Manikhas, A. G., Popova, N. O., Evstigneeva, I. V., Vladimirova, L. Yu, Kramskaya, L. V., Karandeeva, T. V., Suslova, I. R., Romanchuk, O. V., Shikina, V. E., Povyshev, A. Yu, Osipov, M. A., Cherniakova, E. M., Dergunov, A. S., Volkonskiy, M. V., Chernov, I. S., Shumskaya, I. E., Fael, M. M., Garifullina, V. I., Gudkova, I. E.
Published in Medicinskij sovet (08.12.2021)
Published in Medicinskij sovet (08.12.2021)
Get full text
Journal Article